Share Name Share Symbol Market Type Share ISIN Share Description
Eco Animal Health Group LSE:EAH London Ordinary Share GB0032036807 ORD 5P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 657.50p 645.00p 670.00p 657.50p 657.50p 657.50p 5,155 07:47:53
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology 61.4 13.5 16.4 40.2 419.73

Eco Animal Health Share Discussion Threads

Showing 801 to 824 of 825 messages
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
DateSubjectAuthorDiscuss
21/8/2017
13:09
Second biggest egg market in the Middle East so not insignificant.
topvest
21/8/2017
09:16
Another regulatory approval this morning. Not the biggest of markets, but a welcome addition nonetheless less.
aimingupward2
16/8/2017
09:10
Thanks topvest. In my inability to sleep last night I did a bit of research and see he has been gradually selling chunks for a long time without detriment to the share price but I'd love to see the share price if institutions were having to buy in the market.
mad foetus
16/8/2017
09:03
Yes, but he's probably being tempted by continuing demand from institutional investors, as its pretty much the only way in. Hadn't noticed the impressive collection of investors now into this one. See hxxp://www.ecoanimalhealthgroupplc.com/investor-relations/rule-26.aspx
topvest
16/8/2017
03:25
More sales from the CEO, another £4.5m banked. I'm kind of torn: always unhappy to see director sales but pleased that someone else has invested £4.5m at 650p. I would like to see the share price start moving forward now though.
mad foetus
14/8/2017
07:52
More good news, the approvals keep coming.
mad foetus
08/8/2017
10:58
Hi folks...welcome to the new holders! There's no doubt that this little gem has a way to go yet in terms of share price potential. The major investment in developing the regulatory data package is behind them so now their main costs are for the approval applications and enhancing the regulatory data package as and when required to secure new approvals or meet new requirements. They have good patent protection and, because the molecule (Tylvalosin) is hard (and expensive!) to make, the likelihood of illegal copies is very low. Add to this the strong branding for Aivlosin and the excellent low residue profile (which the regulators like) then they have a world of opportunity to aim for. Tanners - had to laugh at your historical analysis! I think it was 2008/2009 when I first bought in at about 195p. I can't remember exactly how I came across the company but I was convinced that it was a good long-term investment. I think the price fell to about 140 not long afterwards so I had to nurse a paper loss for a while. But it came good in the end.....! I think there has to be optimism that there is a lot more upside to come not only from Aivlosin, but their other older products are also growing in sales and profitability. I think £10 has to be a realistic prospect within a 2-year time-frame.
audigger
06/8/2017
22:58
A bit of fun so I had a quick look back at the old thread and found this post of mine.....tho at the time never thought it would take that long! tanners 25 Jul '07 - 23:25 - 579 of 585    0   0   Edit I've been a long term follower of this stock, but I've gotta say, these latest results are poor. For the last 3 years or so, income has been generated by various selling of bits of the business, and now it's stripped down to the core, still it can't generate positive cash flow. I sold ages ago at around #3.60 as it I thought it had too far ahead of itself, and I've followed it since looking for a re entry, but I've gotta say I'm disappointed, and think it's still over valued at current prices. Great business model with barriers to entry of it's market, but the earnings just don't justify this price imo, so it's wait and see. Well worth keeping on the watch list, but I won't be tempted until I see better value than currently exists........I've called this down for some time, and sadly I still think it's a one way ticket.
tanners
06/8/2017
22:56
Agreed - good to see some more interest and new investors. And whilst the rise over the last year may put some off, it's worth remembering that they have taken years to develop these products, get the Regulatory approvals and build a customer base. I was invested in their previous incarnation, Lawrence (LAC) nearly 15 years ago, and sold out as I felt the progress was too slow then re invested again last year, having had them on my watch list for over 10 years! Personally, I'm never bothered about buying at a new high, as long as I think there is still value to be had....and that's been the case in my most of my best performing shares.
tanners
03/8/2017
11:48
Nice to see some new contributors here on what is normally a very quiet board. EAH still seems, surprisingly to me, to be 'off the radar' for so many and yet it has a lot going for it as a safe, reliable, growth share.
aimingupward2
02/8/2017
14:14
And you Jim, great minds thinking alike! I've had a great run recently with BUR, IQE and TAP all doing the business, but I have high hopes here and also for HCM. Big growth, growing margins, untapped market and profitable. A lot to like here.
mad foetus
02/8/2017
13:25
Mad, Good to see you invested here.
jimbowen30
02/8/2017
11:55
I've bought a few today, may well be just an initial tranche if things pan out.
mad foetus
28/7/2017
12:19
Just added another couple of 9k tranches.
monnow
27/7/2017
12:10
Some good points. I bought an initial stake yesterday and see this very much a long term holding.
jimbowen30
25/7/2017
12:19
Also giving confidence is, as I have mentioned before, Peel Hunt's view at the time of the results at the end of June, that EAH has a period of "stellar growth" ahead of it. That's not the sort of phrase they would use lightly, I wouldn't have thought. Of how many other companies have they said that, I wonder. Very (or very, very) few I suspect.
aimingupward2
24/7/2017
23:49
jimbowen30 - I for one wouldn't still be invested if I didn't think there wasn't further significant growth. One of the key metrics I like about ECO is that a rise in turnover is reflected by a disproportionately bigger rise in net profits, and therefore EPS.....which is usually a strong indicator of a unique product/brand. To give an example, over the last 3 years turnover has increased just under 100% (£32M to £61M), whereas EPS have increased by 270% (4.35p to 16.17p). China, Japan & the Indian sub continent were the main reason for the growth last year, but from the interims the current year has started at record levels, and the number of new Regulatory Approvals is also increasing: 2014 - 3, 2015 - 2, 2016 - 5, 2017 - 3 to date. Of the 5 granted in the calendar year 2016, 2 were late in the year therefore the will have a full impact in this financial current year. My mindset is that significant growth is still achievable for some time to come, which therefore justifies a current P/E ratio which might look pricey at first glance.
tanners
24/7/2017
23:08
I have been following the company closely for a while now but haven't bought in yet. Do you all still see a lot of further upside, given the valuation?
jimbowen30
24/7/2017
22:58
Thanks aimingupward. Yes I am very much onboard,Although I am a seasoned investor, my attention was originally drawn to eco, through my small upland sheep farm, and the associated parallels that draws.
monnow
24/7/2017
20:42
Welcome aboard, monnow (assuming you are 'on board', that is). How did you find us I wonder?
aimingupward2
24/7/2017
19:19
5 actually Topvest. Cant believe a company growing eps and turnover so fast is so under the radar !!
monnow
24/7/2017
18:18
Really good news that there are only 4 of us on the BB on a day like today. Bodes well when others decide they like the story as well. Rare stock this one. A storyboard stock which has delivered but no interest. Very different to the likes of say Fevertree that has also delivered, but everyone is in it.
topvest
24/7/2017
08:56
Indeed this certainly opens up lots more business opportunity and should reflect in a further healthy increase in the bottom-line.
audigger
24/7/2017
08:00
This is an important approval which the company, and it's brokers, have been looking forward to receiving for some while now. It can be expected to give a significant lift to future U.S sales and put EAH on track to doubling it's share of that major market.
aimingupward2
Chat Pages: 33  32  31  30  29  28  27  26  25  24  23  22  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:34 V: D:20170821 14:08:42